Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for prevention of acute kidney injury after cardiac surgery with cardiopulmonary bypass
ACTRN12606000405516Phase 2Not yet recruiting
- Sponsor
- Austin Hospital
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute kidney failure (AKF) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Acute kidney injury as measured by change in serum creatinine. Planned start Dec 2006; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ACTRN12606000405516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000405516.